2021 Archive

Investigator Insights

5 Questions for Emily Tonorezos, MD, MPH

Emily Tonorezos, MD, MPH and Alex Generous, PhD

Meet Emily Tonorezos, MD, MPH, incoming Division of Cancer Survivorship director, and learn her plans for continuing St. Jude excellence in survivorship research.

Clinical

Trial provides first look at long-term outcomes of childhood immunotherapies

Alex Generous, PhD

Learn how CONQUER is creating the future of survivorship research.

Research

Connecting cases to uncover an ultrarare neurological disorder

Brian O'Flynn, PhD

See how a global genetic search led to an ultrarare epilepsy diagnosis.

Investigator Insights

Putting the patient experience at the center of neurology treatment

Arun Solanki

Meet Arun Solanki, MD, whose career journey has taken him from a private pediatric neurology practice to caring for patients with rare neurologic diseases.

Outreach

Pharmacists close gaps in global cancer care

Heather Johnson

Discover the work of the Global Transversal Pharmacy Program.

Clinical

Emotional health supports physical health in survivors of childhood cancer

Alex Generous, PhD

Learn how providing psychological support improves markers of inflammation.

St. Jude On

A people-first approach guides technology transformation in radiology

Brian O'Flynn, PhD

Learn about the tools ushering in a new age of radiology research

Research

Vitamin C emerges as an unexpected guardian against autoimmunity

Alex Generous, PhD

Find out how the nutrient is central to preventing autoreactive T cells from causing autoimmune attacks.

St. Jude On

The hidden inheritance behind cancer risk and development

LaToyia P. Downs, PhD

Discover how St. Jude researchers are advancing our understanding of inherited genetic risk factors to improve cancer detection, prevention and personalized treatment.

Investigator Insights

5 Questions for Mengzhao (Lucy) Xue, PhD

Mengzhao (Lucy) Xue and LaToyia P. Downs, PhD

Explore the work and achievements of Mengzhao (Lucy) Xue, PhD, as she shares her research journey and what receiving the 2026 Burroughs Wellcome Fund Career Award means for her career path.

Research

Identifying risks and restrictions: Rehabilitation and cancer survivorship

St. Jude Communications Department

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Research

Getting to the bottom of a medulloblastoma mystery

Erin Podolak, MA

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

Clinical

NCCN publishes guidelines for standardized treatment of Wilms tumor

St. Jude Strategic Communication, Education and Outreach Department

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

Research

For the growing number of childhood cancer survivors, five-year survival is just the beginning

AnnaLynn Williams, PhD

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

Outreach

Advocating globally for a COVID-19 vaccine

Miguela Caniza, MD, MPH

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

Outreach

We can – we will – accelerate progress globally

James R. Downing, MD

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Research

The heart of the matter – cancer survivors and heart disease

Matthew J. Ehrhardt, MD

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Research

Immune markers offer clues to antibody production in response to flu

Mary Powers

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

Clinical

Cancer care during a pandemic: What we learned prepares us for the next emergency

Dylan Graetz, MD, MPH

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Outreach

Learning the value of mentors, champions and building a strong network

St. Jude Progress

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.